Pharvaris NV

NASDAQ:PHVS  
27.32
-0.46 (-1.66%)
4:00:02 PM EDT: $27.32 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Pharvaris NV Stock, NASDAQ:PHVS

Emmy Noetherweg 2, J.H. Oortweg 21, Leiden, Zuid-Holland 2333 BK
Netherlands
Phone: +31.71.203.64.10
Number of Employees: 65

Description

Pharvaris NV operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. Its PHA121 program is designed to treat all sub-types of hereditary angioedema. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Hans Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.